相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Increasing Consumption of Antibiotics during the COVID-19 Pandemic: Implications for Patient Health and Emerging Anti-Microbial Resistance
Shahana Seher Malik et al.
ANTIBIOTICS-BASEL (2023)
Bronchoalveolar lavage fluid polymerase chain reaction for invasive pulmonary aspergillosis among high-risk patients: a diagnostic meta-analysis
Yinling Han et al.
BMC PULMONARY MEDICINE (2023)
Global antibiotic use during the COVID-19 pandemic: analysis of pharmaceutical sales data from 71 countries, 2020-2022
Arindam Nandi et al.
ECLINICALMEDICINE (2023)
Comparing the clinical characteristics and outcomes of COVID-19-associate pulmonary aspergillosis (CAPA): a systematic review and meta-analysis
Woon Hean Chong et al.
INFECTION (2022)
Inhaled amphotericin B lipid complex for prophylaxis against COVID-19-associated invasive pulmonary aspergillosis
Maria Cruz Soriano et al.
INTENSIVE CARE MEDICINE (2022)
Combination of Mycological Criteria: a Better Surrogate to Identify COVID-19-Associated Pulmonary Aspergillosis Patients and Evaluate Prognosis?
Sarah Delliere et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2022)
Coronavirus Disease 2019-Associated Pulmonary Aspergillosis in Mechanically Ventilated Patients
Nitipong Permpalung et al.
CLINICAL INFECTIOUS DISEASES (2022)
Results from a national survey on COVID-19-associated mucormycosis in Germany: 13 patients from six tertiary hospitals
Danila Seidel et al.
MYCOSES (2022)
Mucormycosis (black fungus) ensuing COVID-19 and comorbidity meets- Magnifying global pandemic grieve and catastrophe begins
Karthika Pushparaj et al.
SCIENCE OF THE TOTAL ENVIRONMENT (2022)
COVID-19-associated pulmonary aspergillosis in a tertiary care center in Shenzhen City
Zhaofang Jiang et al.
JOURNAL OF INFECTION AND PUBLIC HEALTH (2022)
The emergence of COVID-19 associated mucormycosis: a review of cases from 18 countries
Martin Hoenigl et al.
LANCET MICROBE (2022)
Impact of COVID-19 on an infection prevention and control program, Iowa 2020-2021
Mohammed Alsuhaibani et al.
AMERICAN JOURNAL OF INFECTION CONTROL (2022)
Risk factors and outcome of pulmonary aspergillosis in critically ill coronavirus disease 2019 patients-a multinational observational study by the European Confederation of Medical Mycology
Juergen Prattes et al.
CLINICAL MICROBIOLOGY AND INFECTION (2022)
Let's talk about sex characteristics-As a risk factor for invasive fungal diseases
Matthias Egger et al.
MYCOSES (2022)
Tackling the emerging threat of antifungal resistance to human health
Matthew C. Fisher et al.
NATURE REVIEWS MICROBIOLOGY (2022)
Antibiotic use and Influencing Factors Among Hospitalized Patients with COVID-19: A Multicenter Point-Prevalence Study from Turkey
Irfan Sencan et al.
BALKAN MEDICAL JOURNAL (2022)
Prevalence of COVID-19-Associated Pulmonary Aspergillosis: Critical Review and Conclusions
Matthias Egger et al.
JOURNAL OF FUNGI (2022)
COVID-19-associated fungal infections
Martin Hoenigl et al.
NATURE MICROBIOLOGY (2022)
Prevalence of Fungal Drug Resistance in COVID-19 Infection: a Global Meta-analysis
Adrina Habibzadeh et al.
CURRENT FUNGAL INFECTION REPORTS (2022)
Exploring SARS-CoV2 host-pathogen interactions and associated fungal infections cross-talk: Screening of targets and understanding pathogenesis
Abdul Arif Khan et al.
COMPUTATIONAL AND STRUCTURAL BIOTECHNOLOGY JOURNAL (2022)
Risk Factors for Coronavirus Disease 2019 (COVID-19)-Associated Pulmonary Aspergillosis in Critically Ill Patients: A Nationwide, Multicenter, Retrospective Cohort Study
Si-Ho Kim et al.
JOURNAL OF KOREAN MEDICAL SCIENCE (2022)
COVID Induced Functional Exhaustion and Persistently Reduced Lymphocytes as Vital Contributing Factors for Post-COVID Rhino-orbital and Cerebral Mucormycosis in Patients with Diabetes: Report from the Indian Sub-continent
Darpan Bhargava et al.
HEAD & NECK PATHOLOGY (2022)
Antifungal Drug Resistance: Molecular Mechanisms in Candida albicans and Beyond
Yunjin Lee et al.
CHEMICAL REVIEWS (2021)
Epidemiology of Invasive Pulmonary Aspergillosis Among Intubated Patients With COVID-19: A Prospective Study
Michele Bartoletti et al.
CLINICAL INFECTIOUS DISEASES (2021)
Invasive Fungal Disease Complicating Coronavirus Disease 2019: When It Rains, It Spores
Martin Hoenigl
CLINICAL INFECTIOUS DISEASES (2021)
A National Strategy to Diagnose Coronavirus Disease 2019-Associated Invasive Fungal Disease in the Intensive Care Unit
P. Lewis White et al.
CLINICAL INFECTIOUS DISEASES (2021)
Public health issues with Candida auris in COVID-19 patients
Edmund J. Janniger et al.
WORLD MEDICAL & HEALTH POLICY (2021)
Outbreak of Candida auris infection in a COVID-19 hospital in Mexico
Hiram Villanueva-Lozano et al.
CLINICAL MICROBIOLOGY AND INFECTION (2021)
Ravaging SARS-CoV-2: rudimentary diagnosis and puzzling immunological responses
Tapan Kumar Mukherjee et al.
CURRENT MEDICAL RESEARCH AND OPINION (2021)
A challenging complication following SARS-CoV-2 infection: a case of pulmonary mucormycosis
Daniela Pasero et al.
INFECTION (2021)
Diagnosis of invasive fungal disease in coronavirus disease 2019: approaches and pitfalls
P. Lewis White
CURRENT OPINION IN INFECTIOUS DISEASES (2021)
An approach to develop clinical prediction rule for candidemia in critically ill patients: A retrospective observational study
Ahmad Shafie Jameran et al.
JOURNAL OF CRITICAL CARE (2021)
Spread of Carbapenem-Resistant Gram-Negatives and Candida auris during the COVID-19 Pandemic in Critically Ill Patients: One Step Back in Antimicrobial Stewardship?
Laura Magnasco et al.
MICROORGANISMS (2021)
Dexamethasone Promotes Aspergillus fumigatus Growth in Macrophages by Triggering M2 Repolarization via Targeting PKM2
Maureen K. Luvanda et al.
JOURNAL OF FUNGI (2021)
Specificity Influences in (1→3)-β-d-Glucan-Supported Diagnosis of Invasive Fungal Disease
Malcolm A. Finkelman
JOURNAL OF FUNGI (2021)
C. auris and non-C. auris candidemia in hospitalized adult and pediatric COVID-19 patients; single center data from Pakistan
Safia Moin et al.
MEDICAL MYCOLOGY (2021)
COVID-19 Impairs Immune Response to Candida albicans
Dominique Moser et al.
FRONTIERS IN IMMUNOLOGY (2021)
Epidemiology of Mucormycosis in India
Hariprasath Prakash et al.
MICROORGANISMS (2021)
First Candida auris Outbreak during a COVID-19 Pandemic in a Tertiary-Care Center in Lebanon
Fatima Allaw et al.
PATHOGENS (2021)
Molecular Epidemiological Investigation of a Nosocomial Cluster of C. auris: Evidence of Recent Emergence in Italy and Ease of Transmission during the COVID-19 Pandemic
Vincenzo Di Pilato et al.
JOURNAL OF FUNGI (2021)
The chaperone GRP78 is a host auxiliary factor for SARS-CoV-2 and GRP78 depleting antibody blocks viral entry and infection
Anthony J. Carlos et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2021)
Investigating Candida glabrata Urinary Tract Infections (UTIs) in Mice Using Bioluminescence Imaging
Sanne Schrevens et al.
JOURNAL OF FUNGI (2021)
Axillary Digital Thermometers uplifted a multidrug-susceptible Candida auris outbreak among COVID-19 patients in Brazil
Joao Nobrega de Almeida et al.
MYCOSES (2021)
Co-Infections in Critically Ill Patients with or without COVID-19: A Comparison of Clinical Microbial Culture Findings
Rosario Cultrera et al.
INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH (2021)
Candidemia among Iranian Patients with Severe COVID-19 Admitted to ICUs
Amir Arastehfar et al.
JOURNAL OF FUNGI (2021)
When Uncontrolled Diabetes Mellitus and Severe COVID-19 Converge: The Perfect Storm for Mucormycosis
Teny M. John et al.
JOURNAL OF FUNGI (2021)
COVID-19-associated pulmonary aspergillosis (CAPA): how big a problem is it?
Arnaud Fekkar et al.
CLINICAL MICROBIOLOGY AND INFECTION (2021)
Comparison of clinical features and outcomes in COVID-19 and influenza pneumonia patients requiring intensive care unit admission
A. Oliva et al.
INFECTION (2021)
Taskforce report on the diagnosis and clinical management of COVID-19 associated pulmonary aspergillosis
Paul E. Verweij et al.
INTENSIVE CARE MEDICINE (2021)
Diagnosis and treatment of COVID-19 associated pulmonary apergillosis in critically ill patients: results from a European confederation of medical mycology registry
Juergen Prattes et al.
INTENSIVE CARE MEDICINE (2021)
COVID-19 associated pulmonary aspergillosis: regional variation in incidence and diagnostic challenges
Juergen Prattes et al.
INTENSIVE CARE MEDICINE (2021)
Clinical and microbiological features and outcomes of mucormycosis in critically ill patients
Kathrin Rothe et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2021)
Predisposing factors of important invasive fungal coinfections in COVID-19 patients: a review article
Mohammadali Zia et al.
JOURNAL OF INTERNATIONAL MEDICAL RESEARCH (2021)
COVID-19-Associated Pulmonary Aspergillosis at an Academic Medical Center in the Midwestern United States
Anastasia Wasylyshyn et al.
MYCOPATHOLOGIA (2021)
Characteristics of candidemia in COVID-19 patients; increased incidence, earlier occurrence and higher mortality rates compared to non-COVID-19 patients
Bircan Kayaaslan et al.
MYCOSES (2021)
Understanding the role of ACE-2 receptor in pathogenesis of COVID-19 disease: a potential approach for therapeutic intervention
Ekta Shirbhate et al.
PHARMACOLOGICAL REPORTS (2021)
Aspergillus fumigatus and aspergillosis: From basics to clinics
A. Arastehfar et al.
STUDIES IN MYCOLOGY (2021)
Rising incidence of mucormycosis in patients with COVID-19: another challenge for India amidst the second wave?
Akshay Raut et al.
LANCET RESPIRATORY MEDICINE (2021)
Low-Grade Endotoxemia and Thrombosis in COVID-19
Alessandra Oliva et al.
CLINICAL AND TRANSLATIONAL GASTROENTEROLOGY (2021)
Persistent Systemic Microbial Translocation and Intestinal Damage During Coronavirus Disease-19
Alessandra Oliva et al.
FRONTIERS IN IMMUNOLOGY (2021)
A High Frequency of Candida auris Blood Stream Infections in Coronavirus Disease 2019 Patients Admitted to Intensive Care Units, Northwestern India: A Case Control Study
Ekadashi Rajni et al.
OPEN FORUM INFECTIOUS DISEASES (2021)
Multinational Observational Cohort Study of COVID-19-Associated Pulmonary Aspergillosis1
Nico A. F. Janssen et al.
EMERGING INFECTIOUS DISEASES (2021)
Multicenter Epidemiologic Study of Coronavirus Disease-Associated Mucormycosis, India
Atul Patel et al.
EMERGING INFECTIOUS DISEASES (2021)
COVID-19-Associated Pulmonary Aspergillosis, March-August 2020
Jon Salmanton-Garcia et al.
EMERGING INFECTIOUS DISEASES (2021)
The role of co-infections and secondary infections in patients with COVID-19
Charles Feldman et al.
PNEUMONIA (2021)
Therapeutic role of corticosteroids in COVID-19: a systematic review of registered clinical trials
Reshma Raju et al.
FUTURE JOURNAL OF PHARMACEUTICAL SCIENCES (2021)
SARS-CoV-2, Uncontrolled Diabetes and Corticosteroids-An Unholy Trinity in Invasive Fungal Infections of the Maxillofacial Region? A Retrospective, Multi-centric Analysis
Aditya Moorthy et al.
JOURNAL OF MAXILLOFACIAL & ORAL SURGERY (2021)
Multi-triazole-resistant Aspergillus fumigatus and SARS-CoV-2 co-infection: A lethal combination
Aia Mohamed et al.
MEDICAL MYCOLOGY CASE REPORTS (2021)
Recovery of a triazole-resistant Aspergillus fumigatus in respiratory specimen of COVID-19 patient in ICU - A case report
Theo Ghelfenstein-Ferreira et al.
MEDICAL MYCOLOGY CASE REPORTS (2021)
SARS-CoV-2 infects and replicates in cells of the human endocrine and exocrine pancreas
Janis A. Mueller et al.
NATURE METABOLISM (2021)
Viral respiratory infections: a cause of community-acquired pneumonia or a predisposing factor?
Forest W. Arnold et al.
CURRENT OPINION IN PULMONARY MEDICINE (2020)
Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target
Haibo Zhang et al.
INTENSIVE CARE MEDICINE (2020)
Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China
Qiurong Ruan et al.
INTENSIVE CARE MEDICINE (2020)
Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China
Dawei Wang et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Pulmonary Pathology of Early-Phase 2019 Novel Coronavirus (COVID-19) Pneumonia in Two Patients With Lung Cancer
Sufang Tian et al.
JOURNAL OF THORACIC ONCOLOGY (2020)
Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury
Clark D. Russell et al.
LANCET (2020)
Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study
Nanshan Chen et al.
LANCET (2020)
A pneumonia outbreak associated with a new coronavirus of probable bat origin
Peng Zhou et al.
NATURE (2020)
Clinical Characteristics of Coronavirus Disease 2019 in China
W. Guan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
SARS-CoV-2 Viral Load in Upper Respiratory Specimens of Infected Patients
Lirong Zou et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus-Infected Pneumonia
Qun Li et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Mucormycosis
Gail Reid et al.
SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE (2020)
High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa
Hao Xu et al.
INTERNATIONAL JOURNAL OF ORAL SCIENCE (2020)
The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2
Alexander E. Gorbalenya et al.
NATURE MICROBIOLOGY (2020)
COVID-19-associated Pulmonary Aspergillosis
Andreas L. E. van Arkel et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2020)
SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
Markus Hoffmann et al.
CELL (2020)
Hematologic, biochemical and immune biomarker abnormalities associated with severe illness and mortality in coronavirus disease 2019 (COVID-19): a meta-analysis
Brandon Michael Henry et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2020)
Coronavirus Disease 2019, Superinfections, and Antimicrobial Development: What Can We Expect?
Cornelius J. Clancy et al.
CLINICAL INFECTIOUS DISEASES (2020)
Dysregulation of Immune Response in Patients With Coronavirus 2019 (COVID-19) in Wuhan, China
Chuan Qin et al.
CLINICAL INFECTIOUS DISEASES (2020)
Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study
Xiaobo Yang et al.
Lancet Respiratory Medicine (2020)
Pathological findings of COVID-19 associated with acute respiratory distress syndrome
Zhe Xu et al.
LANCET RESPIRATORY MEDICINE (2020)
A Review of Coronavirus Disease-2019 (COVID-19)
Tanu Singhal
INDIAN JOURNAL OF PEDIATRICS (2020)
Bacterial and fungal infections in COVID-19 patients: A matter of concern
Pengcheng Zhou et al.
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY (2020)
Candida auris Isolates Resistant to Three Classes of Antifungal Medications — New York, 2019
Belinda Ostrowsky et al.
MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2020)
Clinical and immunological features of severe and moderate coronavirus disease 2019
Guang Chen et al.
JOURNAL OF CLINICAL INVESTIGATION (2020)
Co-infections in people with COVID-19: a systematic review and meta-analysis
Louise Lansbury et al.
JOURNAL OF INFECTION (2020)
The presence of SARS-CoV-2 RNA in the feces of COVID-19 patients
Yifei Chen et al.
JOURNAL OF MEDICAL VIROLOGY (2020)
GRP78 and Integrins Play Different Roles in Host Cell Invasion during Mucormycosis
Abdullah Alqarihi et al.
MBIO (2020)
Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China
Chaomin Wu et al.
JAMA INTERNAL MEDICINE (2020)
Investigation of three clusters of COVID-19 in Singapore: implications for surveillance and response measures
Rachael Pung et al.
LANCET (2020)
Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study
Fei Zhou et al.
LANCET (2020)
COVID-19-associated invasive pulmonary aspergillosis
Lynn Rutsaert et al.
ANNALS OF INTENSIVE CARE (2020)
Prevalence of putative invasive pulmonary aspergillosis in critically ill patients with COVID-19
Alexandre Alanio et al.
LANCET RESPIRATORY MEDICINE (2020)
Pathogenic T-cells and inflammatory monocytes incite inflammatory storms in severe COVID-19 patients
Yonggang Zhou et al.
NATIONAL SCIENCE REVIEW (2020)
COVID-19 associated pulmonary aspergillosis
Philipp Koehler et al.
MYCOSES (2020)
Detection of Invasive Pulmonary Aspergillosis in COVID-19 with Nondirected BAL
Stefaan Van Biesen et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2020)
Incidence of invasive pulmonary aspergillosis among critically ill COVID-19 patients
Frederic Lamoth et al.
CLINICAL MICROBIOLOGY AND INFECTION (2020)
The microbial coinfection in COVID-19
Xi Chen et al.
APPLIED MICROBIOLOGY AND BIOTECHNOLOGY (2020)
Aspergillus fumigatusand pan-azole resistance: who should be concerned?
Nathan P. Wiederhold et al.
CURRENT OPINION IN INFECTIOUS DISEASES (2020)
High prevalence of COVID-19-associated diabetic ketoacidosis in UK secondary care
Nina Goldman et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2020)
Secondary Bacterial Infections During Pulmonary Viral Disease: Phage Therapeutics as Alternatives to Antibiotics?
Prasanth Manohar et al.
FRONTIERS IN MICROBIOLOGY (2020)
Review of influenza-associated pulmonary aspergillosis in ICU patients and proposal for a case definition: an expert opinion
Paul E. Verweij et al.
INTENSIVE CARE MEDICINE (2020)
Invasive fungal diseases during COVID-19: We should be prepared
J. -P. Gangneux et al.
JOURNAL DE MYCOLOGIE MEDICALE (2020)
Clinical Significance of the Correlation between Changes in the Major Intestinal Bacteria Species and COVID-19 Severity
Lingling Tang et al.
ENGINEERING (2020)
Secondary Bacterial Infections in Patients With Viral Pneumonia
Prasanth Manohar et al.
FRONTIERS IN MEDICINE (2020)
Is the COVID-19 Pandemic a Good Time to IncludeAspergillusMolecular Detection to Categorize Aspergillosis in ICU Patients? A Monocentric Experience
Jean-Pierre Gangneux et al.
JOURNAL OF FUNGI (2020)
COVID-19 Associated Pulmonary Aspergillosis (CAPA)-From Immunology to Treatment
Amir Arastehfar et al.
JOURNAL OF FUNGI (2020)
Azole-Resistant COVID-19-Associated Pulmonary Aspergillosis in an Immunocompetent Host: A Case Report
Eelco F. J. Meijer et al.
JOURNAL OF FUNGI (2020)
Co-infection with respiratory pathogens among COVID-2019 cases
Xiaojuan Zhu et al.
VIRUS RESEARCH (2020)
The lurking scourge of multidrug resistant Candida auris in times of COVID-19 pandemic
Anuradha Chowdhary et al.
JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE (2020)
Pan-Echinocandin-Resistant Candida glabrata Bloodstream Infection Complicating COVID-19: A Fatal Case Report
Brunella Posteraro et al.
JOURNAL OF FUNGI (2020)
COVID-19-Associated Candidiasis (CAC): An Underestimated Complication in the Absence of Immunological Predispositions?
Amir Arastehfar et al.
JOURNAL OF FUNGI (2020)
COVID-19: An Emerging Threat to Antibiotic Stewardship in the Emergency Department
Michael S. Pulia et al.
WESTERN JOURNAL OF EMERGENCY MEDICINE (2020)
Defining and managing COVID-19-associated pulmonary aspergillosis: the 2020 ECMM/ISHAM consensus criteria for research and clinical guidance
Philipp Koehler et al.
LANCET INFECTIOUS DISEASES (2020)
Corticosteroid use in COVID-19 patients: a systematic review and meta-analysis on clinical outcomes
Judith van Paassen et al.
CRITICAL CARE (2020)
Is the Frequency of Candidemia Increasing in COVID-19 Patients Receiving Corticosteroids?
Cezar V. W. Riche et al.
JOURNAL OF FUNGI (2020)
Multidrug-Resistant Candida auris Infections in Critically III Coronavirus Disease Patients, India, April-July 2020
Anuradha Chowdhary et al.
EMERGING INFECTIOUS DISEASES (2020)
COVID-19: immunopathogenesis and Immunotherapeutics
Li Yang et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2020)
Role of angiotensin-converting enzyme 2 (ACE2) in COVID-19
Wentao Ni et al.
CRITICAL CARE (2020)
Viral Load Kinetics of SARS-CoV-2 Infection in First Two Patients in Korea
Jin Yong Kim et al.
JOURNAL OF KOREAN MEDICAL SCIENCE (2020)
The epidemiology and clinical manifestations of mucormycosis: a systematic review and meta-analysis of case reports
W. Jeong et al.
CLINICAL MICROBIOLOGY AND INFECTION (2019)
ESICM/ESCMID task force on practical management of invasive candidiasis in critically ill patients
Ignacio Martin-Loeches et al.
INTENSIVE CARE MEDICINE (2019)
Severe Acute Respiratory Syndrome Coronavirus Viroporin 3a Activates the NLRP3 Inflammasome
I-Yin Chen et al.
FRONTIERS IN MICROBIOLOGY (2019)
False positive bronchoalveolar lavage galactomannan: Effect of host and cut-off value
Dimitrios Farmakiotis et al.
MYCOSES (2019)
Candida auris: A systematic review and meta-analysis of current updates on an emerging multidrug-resistant pathogen
John Osei Sekyere
MICROBIOLOGYOPEN (2018)
Iron restriction inside macrophages regulates pulmonary host defense against Rhizopus species
Angeliki M. Andrianaki et al.
NATURE COMMUNICATIONS (2018)
Invasive pulmonary aspergillosis complicating severe influenza: epidemiology, diagnosis and treatment
Lore Vanderbeke et al.
CURRENT OPINION IN INFECTIOUS DISEASES (2018)
Candida auris: a Review of the Literature
Anna Jeffery-Smith et al.
CLINICAL MICROBIOLOGY REVIEWS (2018)
Pulmonary mucormycosis: clinical features and outcomes
Erica Lin et al.
INFECTION (2017)
Bicarbonate correction of ketoacidosis alters host-pathogen interactions and alleviates mucormycosis
Teclegiorgis Gebremariam et al.
JOURNAL OF CLINICAL INVESTIGATION (2016)
An integrated genomic and transcriptomic survey of mucormycosis-causing fungi
Marcus C. Chibucos et al.
Nature Communications (2016)
The clinical spectrum of pulmonary aspergillosis
Chris Kosmidis et al.
THORAX (2015)
CotH3 mediates fungal invasion of host cells during mucormycosis
Teclegiorgis Gebremariam et al.
JOURNAL OF CLINICAL INVESTIGATION (2014)
Mucormycosis in India: unique features
Arunaloke Chakrabarti et al.
MYCOSES (2014)
Candida albicans pathogenicity mechanisms
Francois L. Mayer et al.
VIRULENCE (2013)
A Clinical Algorithm to Diagnose Invasive Pulmonary Aspergillosis in Critically Ill Patients
Stijn I. Blot et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2012)
The strategy for the diagnosis of invasive pulmonary aspergillosis should depend on both the underlying condition and the leukocyte count of patients with hematologic malignancies
Anne Bergeron et al.
BLOOD (2012)
ESCMID* guideline for the diagnosis and management of Candida diseases 2012: non-neutropenic adult patients
O. A. Cornely et al.
CLINICAL MICROBIOLOGY AND INFECTION (2012)
Recognition of fungal RNA by TLR7 has a nonredundant role in host defense against experimental candidiasis
Carmelo Biondo et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2012)
Detection of Galactomannan in Bronchoalveolar Lavage Fluid Samples of Patients at Risk for Invasive Pulmonary Aspergillosis: Analytical and Clinical Validity
Jorien D'Haese et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2012)
Dexamethasone as adjunctive therapy for treatment of varicella pneumonia
Mohamed A. Saraya et al.
EGYPTIAN JOURNAL OF CHEST DISEASES AND TUBERCULOSIS (2012)
Mucorales-specific T cells emerge in the course of invasive mucormycosis and may be used as a surrogate diagnostic marker in high-risk patients
Leonardo Potenza et al.
BLOOD (2011)
β-D-Glucan Assay for the Diagnosis of Invasive Fungal Infections: A Meta-analysis
Drosos E. Karageorgopoulos et al.
CLINICAL INFECTIOUS DISEASES (2011)
Host cell invasion in mucormycosis: role of iron
Ashraf S. Ibrahim
CURRENT OPINION IN MICROBIOLOGY (2011)
Conventional Dendritic Cells Mount a Type I IFN Response against Candida spp. Requiring Novel Phagosomal TLR7-Mediated IFN-β Signaling
Christelle Bourgeois et al.
JOURNAL OF IMMUNOLOGY (2011)
The endothelial cell receptor GRP78 is required for mucormycosis pathogenesis in diabetic mice
Mingfu Liu et al.
JOURNAL OF CLINICAL INVESTIGATION (2010)
The high affinity iron permease is a key virulence factor required for Rhizopus oryzae pathogenesis
Ashraf S. Ibrahim et al.
MOLECULAR MICROBIOLOGY (2010)
The use of mannan antigen and anti-mannan antibodies in the diagnosis of invasive candidiasis: recommendations from the Third European Conference on Infections in Leukemia
Malgorzata Mikulska et al.
CRITICAL CARE (2010)
Pathogenesis of Aspergillus fumigatus in Invasive Aspergillosis
Taylor R. T. Dagenais et al.
CLINICAL MICROBIOLOGY REVIEWS (2009)
Usefulness of the Candida score for discriminating between Candida colonization and invasive candidiasis in non-neutropenic critically ill patients: A prospective multicenter study
Cristobal Leon et al.
CRITICAL CARE MEDICINE (2009)
Severe Acute Respiratory Syndrome Coronavirus Papain-Like Protease Ubiquitin-Like Domain and Catalytic Domain Regulate Antagonism of IRF3 and NF-κB Signaling
Matthew Frieman et al.
JOURNAL OF VIROLOGY (2009)
Genomic and non-genomic effects of dexamethasone on equine peripheral blood neutrophils
L. Lecoq et al.
VETERINARY IMMUNOLOGY AND IMMUNOPATHOLOGY (2009)
The discovery of angiotensin-converting enzyme 2 and its role in acute lung injury in mice
Yumiko Imai et al.
EXPERIMENTAL PHYSIOLOGY (2008)
Severe acute respiratory syndrome coronavirus nsp1 suppresses host gene expression, including that of type I interferon, in infected cells
Krishna Narayananj et al.
JOURNAL OF VIROLOGY (2008)
Mutations in the multi-drug resistance regulator MRR1, followed by loss of heterozygosity, are the main cause of MDR1 overexpression in fluconazole-resistant Candida albicans strains
Nico Dunkel et al.
MOLECULAR MICROBIOLOGY (2008)
Severe acute respiratory syndrome coronavirus ORF6 antagonizes STAT1 function by sequestering nuclear import factors on the rough endoplasmic Reticulum/Golgi membrane
Matthew Frieman et al.
JOURNAL OF VIROLOGY (2007)
Angiotensin-converting enzyme 2 in lung diseases
Keiji Kuba et al.
CURRENT OPINION IN PHARMACOLOGY (2006)
ACE2 receptor expression and severe acute respiratory syndrome coronavirus infection depend on differentiation of human airway epithelia
HP Jia et al.
JOURNAL OF VIROLOGY (2005)
Inhibitors of cathepsin L prevent severe acute respiratory syndrome coronavirus entry
G Simmons et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury
K Kuba et al.
NATURE MEDICINE (2005)
Multiple organ infection and the pathogenesis of SARS
J Gu et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
Angiotensin-converting enzyme 2 protects from severe acute lung failure
Y Imai et al.
NATURE (2005)
Severe acute respiratory syndrome and the innate immune responses: Modulation of effector cell function without productive infection
CTK Tseng et al.
JOURNAL OF IMMUNOLOGY (2005)
Cytokine responses in severe acute respiratory syndrome coronavirus-infected macrophages in vitro: possible relevance to pathogenesis
CY Cheung et al.
JOURNAL OF VIROLOGY (2005)
Apoptosis, pyroptosis, and necrosis: Mechanistic description of dead and dying eukaryotic cells
SL Fink et al.
INFECTION AND IMMUNITY (2005)
SARS-coronavirus replication in human peripheral monocytes/macrophages
M Yilla et al.
VIRUS RESEARCH (2005)
Plasma inflammatory cytokines and chemokines in severe acute respiratory syndrome
CK Wong et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2004)
Voriconazole - a new therapeutic agent with an extended spectrum of antifungal activity
JP Donnelly et al.
CLINICAL MICROBIOLOGY AND INFECTION (2004)
Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis
I Hamming et al.
JOURNAL OF PATHOLOGY (2004)
Amino acids 270 to 510 of the severe acute respiratory syndrome coronavirus spike protein are required for interaction with receptor
GJ Babcock et al.
JOURNAL OF VIROLOGY (2004)
Investigation of multidrug efflux pumps in relation to fluconazole resistance in Candida albicans biofilms
G Ramage et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2002)